HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

EGF mutant receptor vIII as a molecular target in cancer therapy.

AuthorsC T Kuan, C J Wikstrand, D D Bigner
JournalEndocrine-related cancer (Endocr Relat Cancer) Vol. 8 Issue 2 Pg. 83-96 (Jun 2001) ISSN: 1351-0088 [Print] England
PMID11397666 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review)
Chemical References
  • Antibodies, Monoclonal
  • Immunotoxins
  • epidermal growth factor receptor VIII
  • ErbB Receptors
Topics
  • Animals
  • Antibodies, Monoclonal (immunology, therapeutic use)
  • ErbB Receptors (genetics, immunology)
  • Gene Expression Regulation, Neoplastic
  • Glioblastoma (immunology, therapy)
  • Humans
  • Immunotherapy (methods)
  • Immunotoxins (immunology, therapeutic use)
  • Mutation
  • Neoplasms (immunology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: